Inventor
KAYSER FRANK
US49 patents
⚠️ This page may combine multiple inventors who share the name “KAYSER FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
21 patentsUS10221162B2Mar 5, 2019
Triazole agonists of the APJ receptor
AMGEN INC12 citations92
US9868721B2Jan 16, 2018
Triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9745286B2Aug 29, 2017
Triazole agonists of the APJ receptor
AMGEN INC16 citations92
US9656997B2May 23, 2017
Triazole agonists of the APJ receptor
AMGEN INC16 citations92
US9573936B2Feb 21, 2017
Triazole agonists of the APJ receptor
AMGEN INC19 citations92
US9593129B2Mar 14, 2017
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC5 citations83
US9296736B2Mar 29, 2016
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC7 citations83
US7645779B2Jan 12, 2010
Linked biaryl compounds
AMGEN INC9 citations83
US9376425B2Jun 28, 2016
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
AMGEN INC12 citations82
US7071358B2Jul 4, 2006
Arylsulfonamidobenzylic compounds
AMGEN INC6 citations72
US11046680B1Jun 29, 2021
Heteroaryl-substituted triazoles as APJ receptor agonists
AMGEN INC2 citations62
US10736883B2Aug 11, 2020
Triazole furan compounds as agonists of the APJ receptor
AMGEN INC1 citations62
US7112606B2Sep 26, 2006
Heterocyclic arylsulfonamidobenzylic compounds
AMGEN INC3 citations61
US7358250B2Apr 15, 2008
Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activity
AMGEN INC4 citations60
US11407721B2Aug 9, 2022
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
AMGEN INC0 citations50
US7473703B2Jan 6, 2009
Heterocyclic arylsulfonamidobenzylic compounds
AMGEN INC0 citations50
US7326812B2Feb 5, 2008
Arylsulfonamidobenzylic compounds
AMGEN INC0 citations50
US7511043B2Mar 31, 2009
FXR modulators
AMGEN INC0 citations48
US7674907B2Mar 9, 2010
Furanopyridine derivatives and methods of use
AMGEN INC0 citations41
US7763624B2Jul 27, 2010
Substituted pyrazolo[3,4-d]pyrimidines as ACK-1 and LCK inhibitors
AMGEN INC0 citations39
US7776867B2Aug 17, 2010
Furanopyrimidines
AMGEN INC0 citations37
MERCK & CO INC
16 patentsUS6303637B1Oct 16, 2001
Heterocyclic potassium channel inhibitors
MERCK & CO INC39 citations92
US6194458B1Feb 27, 2001
Benzamide potassium channel inhibitors
MERCK & CO INC43 citations92
US6051590AApr 18, 2000
Immunosuppressant tricyclic compounds
MERCK & CO INC29 citations92
US5952371ASep 14, 1999
Triterpene derivatives with immunosuppressant activity
MERCK & CO INC24 citations92
US5763478AJun 9, 1998
Triterpene derivatives with immunosuppressant activity
MERCK & CO INC24 citations92
US5696156ADec 9, 1997
Triterpene derivatives with immunosuppressant activity
MERCK & CO INC36 citations92
US5679705AOct 21, 1997
Triterpene derivatives with immunosuppressant activity
MERCK & CO INC38 citations92
US6632836B1Oct 14, 2003
Carbocyclic potassium channel inhibitors
MERCK & CO INC45 citations90
US6022890AFeb 8, 2000
Immunosuppressant tetracyclic triterpenes
MERCK & CO INC11 citations74
US5998408ADec 7, 1999
Triterpene derivatives with immunosuppressant activity
MERCK & CO INC14 citations74
US5883119AMar 16, 1999
Triterpene derivatives with immunosuppressant activity
MERCK & CO INC8 citations74
US5874594AFeb 23, 1999
Triterpene derivatives with immunosuppressant activity
MERCK & CO INC11 citations74
US6303593B1Oct 16, 2001
3-thienyl and 3-furanyl pyrrolidine modulators of chemokine receptor activity
MERCK & CO INC8 citations71
US6100293AAug 8, 2000
Tetracyclic triterpene derivatives with immunosuppressant activity
MERCK & CO INC0 citations42
US6083980AJul 4, 2000
Furanyl, tetracyclic triterpene derivatives with immunosuppressant activity
MERCK & CO INC0 citations42
US6455548B2Sep 24, 2002
4-alkyl piperidinyl pyrrolidine modulators of chemokine receptor activity
MERCK & CO INC0 citations36